Not sure Leo can do a Q4 trial if the peer review comes out in September... That's a quick task to get FDA approval and recruit patients that quickly... Leo needs to come clean with more info if he wants the stock to stay above .20...
Desperation at it’s highest form. After 6 months no one wants to partner.
Another key aspect I noticed missing is NO MENTION OF GRANT PROGRESS! Leo knows we won’t get s#it from Uncle Sam. Everyone got free money except for the “Gold Standard”